These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 25266809

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Glycopeptides and the newborn infant's kidney].
    Fanos V, Benini D, Vinco S, Pizzini C, Khoory BJ.
    Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH, Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [Abstract] [Full Text] [Related]

  • 7. Incidence and predictors of vancomycin-associated nephrotoxicity.
    Moh'd H, Kheir F, Kong L, Du P, Farag H, Mohamad A, Zurlo JJ.
    South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N, Maiguma T, Komoto A, Haruki Y, Sugiyama T, Kondo S, Teshima D.
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [Abstract] [Full Text] [Related]

  • 11. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ, Shankar V.
    Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
    [Abstract] [Full Text] [Related]

  • 12. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
    Fullmer A, McCue D, Feng C.
    J Oncol Pharm Pract; 2014 Dec; 20(6):403-8. PubMed ID: 24177356
    [Abstract] [Full Text] [Related]

  • 13. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Komatsu T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K.
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [Abstract] [Full Text] [Related]

  • 14. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
    Ramírez E, Jiménez C, Borobia AM, Tong HY, Medrano N, Krauel-Bidwell L, Carcas AJ, Selgas R, Frías J.
    Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.
    Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A.
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1243-55. PubMed ID: 22411630
    [Abstract] [Full Text] [Related]

  • 16. Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity.
    Choi YC, Saw S, Soliman D, Bingham AL, Pontiggia L, Hunter K, Chuang L, Siemianowski LA, Ereshefsky B, Hollands JM.
    Ann Pharmacother; 2017 Nov; 51(11):937-944. PubMed ID: 28709394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T, Hanada K, Kanno A, Akashi M, Itoh T.
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
    Wong-Beringer A, Joo J, Tse E, Beringer P.
    Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME.
    Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.